Active Ingredient Sorafenib Tosylate

Active Ingredient Details

What is Sorafenib Tosylate?

A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy.

What is the usage for Sorafenib Tosylate?

Sorafenib is used to treat kidney, liver, and thyroid cancer. It works by slowing or stopping the growth of cancer cells.

How many products in the NDC database contain Sorafenib Tosylate?

The NDC database has 10 products with the active ingredient Sorafenib Tosylate. The following table lists all the products that have this active ingredient.

NDC Products with Sorafenib Tosylate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0378-1201Proprietary Name: Sorafenib Tosylate SorafenibTablet, Film CoatedOralMylan Pharmaceuticals Inc.ACTIVE
0480-5425Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralTeva Pharmaceuticals, Inc.ACTIVE
43598-458Proprietary Name: Sorafenib SorafenibTablet, Film CoatedOralDr.reddys Laboratories IncACTIVE
54893-0034Proprietary Name: Sorafenib TosylatePowderMsn Laboratories Private LimitedACTIVE
54893-0089Proprietary Name: Sorafenib Tosylate (form-i)PowderMsn Laboratories Private LimitedACTIVE
59651-649Proprietary Name: Sorafenib TosylatePowderAurobindo Pharma LimitedACTIVE
62207-982Proprietary Name: Sorafenib TosylatePowderGranules India LtdACTIVE
63850-8051Proprietary Name: SorafenibPowderNatco Pharma LimitedACTIVE
68554-0073Proprietary Name: SorafenibPowderHetero Labs LimitedACTIVE
71052-675Proprietary Name: Sorafenib TosylatePowderDarmerica, LlcACTIVE
<